Developing a novel reference region for [18F]PI-2620-PET imaging to facilitate the assessment of 4-repeat tauopathies
Progressive supranuclear palsy (PSP) is a fatal 4-repeat (4R) tauopathy with progressive movement phenotypes. In-vivo 4R tau biomarkers are therefore crucial for PSP diagnosis, monitoring, and treatment evaluation. The tau-PET tracer [18F]PI-2620 binds to 4R tau and shows increased uptake in PSP-associated regions (e.g., globus pallidus), and is therefore a candidate 4R tau biomarker. However, commonly used cerebellar tau-PET reference regions show regional proximity to cerebellar 4R tau deposits in PSP, confounding semiquantitative [18F]PI-2620 assessments. Therefore, we employed bias-free image-derived input function (IDIF) PET quantification to identify an optimized data-driven reference region for assessing 4R tau in PSP. Dynamic [18F]PI-2620 PET (60 min) was acquired in 58 PSP-Richardson Syndrome (PSP-RS) and 18 healthy controls (HC). IDIF-modelling with carotid timeseries derived total distribution volume (VT). Iteratively normalizing VT images to atlas-based white matter (WM), we identified reference candidates maximizing PSP-RS vs. HC pallidum differences. The best-performing WM references were combined to a temporo-orbital WM reference, validated in PSP-nonRS (n = 54), HC (n = 18), and disease controls (α-synucleinopathies, n = 21; Alzheimer’s disease (AD, n = 22) using VT-ratios (VTr) and 20-40min static standardized uptake value ratios (SUVr). Using the data-driven temporo-orbital WM reference, PSP patients showed significantly higher basal ganglia [18F]PI-2620 signal vs. HC compared to cerebellar normalization. Receiver operating curve (ROC) analysis confirmed higher diagnostic accuracy using the temporo-orbital WM reference. Pallidum [18F]PI-2620 showed significant associations with clinical disease severity exclusively when using the novel temporo-orbital WM reference. A data-driven temporo-orbital WM reference optimizes [18F]PI-2620 PET assessment for PSP diagnosis, outperforming conventional cerebellar references used in tau-PET imaging.
Authors
- Norman Koglin (ORCID: https://orcid.org/0000-0001-7583-8201)
- Gérard N. Bischof (ORCID: https://orcid.org/0000-0002-4366-5171)
- Gábor G. Kovács
- Amir Dehsarvi (ORCID: https://orcid.org/0000-0001-7116-9741)
- Andrew Stephens (ORCID: https://orcid.org/0000-0001-5052-6586)
- Anna Dewenter (ORCID: https://orcid.org/0000-0002-5636-196X)
- Anna Steward (ORCID: https://orcid.org/0000-0002-8438-3760)
- Johannes Levin (ORCID: https://orcid.org/0000-0001-5092-4306)
- Carla Palleis (ORCID: https://orcid.org/0000-0002-4331-8145)
- Johannes Gnörich (ORCID: https://orcid.org/0000-0003-1554-7765)
- Sebastian Niclas Roemer (ORCID: https://orcid.org/0000-0003-3423-457X)
- Sabrina Katzdobler (ORCID: https://orcid.org/0000-0002-3512-5984)
- Fabian Hirsch (ORCID: https://orcid.org/0000-0002-5370-4031)
- Günter U. Höglinger (ORCID: https://orcid.org/0000-0001-7587-6187)
- Zeyu Zhu (ORCID: https://orcid.org/0000-0003-0970-4832)
- Lukas Frontzkowski (ORCID: https://orcid.org/0000-0001-9321-956X)
- Nicolai Franzmeier (ORCID: https://orcid.org/0000-0001-9736-2283)
- Davina Biel (ORCID: https://orcid.org/0000-0002-2597-1992)
- Mattes Groß
- Matthias Brendel
- André Müller
Institutions
- University Health Network (CA)
- German Center for Neurodegenerative Diseases (DE)
- LMU Klinikum (DE)
- Occupational Cancer Research Centre (CA)
- Munich Cluster for Systems Neurology (DE)
- Ontario Brain Institute (CA)
- Ludwig-Maximilians-Universität München (DE)
- University of Gothenburg (SE)
Publication Details
- Journal
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2025-06-09
- DOI
- https://doi.org/10.1007/s00259-025-07396-8
- Primary Topic
- Genetic Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00